NFKB1 and diabetes mellitus: Therefore, the combination of high sCD40L levels found in diabetes and the upregulated expression of functional β-cell receptor shown here suggests that TNFR5 signalling may be responsible for much of the glucolipotoxicty-induced NF-κB activity in humans.